Skip to main content
Premium Trial:

Request an Annual Quote

Biocius Life Sciences Forms after Life Tech's Biotrove Acquisition

NEW YORK (GenomeWeb News) – Biocius Life Sciences said today that it is now an independent operating company after completing its spin out from parent company Biotrove, which was recently acquired by Life Technologies.

Biocius said that it now holds all of the intellectual property related to the RapidFire mass spectrometry platform formerly owned by Biotrove; and that it will employ all former employees of Biotrove's RapidFire business unit.

In November, Life Technologies announced that it would acquire BioTrove for an undisclosed sum to incorporate Biotrove's OpenArray high-throughput gene expression and genotyping system.

At the time, Biotrove said that it would form the Biocius subsidiary to retain the RapidFire business. Life Tech's acquisition of Biotrove was completed yesterday.

Biocius' investors include Catalyst Health Ventures, Excel Venture Management, Fletcher-Spaght, CB Health Ventures, Vox Equity Partners, Echelon Ventures, and BioFrontier Partners.

Biocius, based in Woburn, Mass., said that it will focus its resources on further developing and marketing the RapidFire platform, as well as new research and development projects to facilitate drug discovery for clients and collaborators.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.